Öztürk Recep, Arıkan Şefik Murat, Şimşek Mehmet Akif, Özanlağan Emre, Güngör Bedii Şafak
Department of Orthopedics and Traumatology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, 06200 Yenimahalle, Ankara, Turkey.
Eklem Hastalik Cerrahisi. 2017 Aug;28(2):121-7. doi: 10.5606/ehc.2017.52092.
This study aims to evaluate the clinical characteristics and treatment results of patients with a diagnosis of solitary fibrous tumor localized in extremity.
Clinical findings, treatment methods, clinical outcomes and treatment failures of seven patients (3 males, 4 females; mean age 49.7±20.7 years; range 22 to 79 years) diagnosed as solitary fibrous tumor localized in extremity between January 2005 and December 2016 were evaluated retrospectively.
Most frequent localization was the thigh (42.8%, n=3). Mean tumor size was 10.8±2.4 cm (range 8-15 cm). All patients applied with painless mass and all had primary tumor. All patients had localized disease at the time of diagnosis. Postoperative mean follow-up duration was 44.4 months (range 13-121 months). Marginal resection was performed in two patients at low risk group while wide resection was performed in other patients at moderate and high risk groups. Patients who underwent marginal resection were performed adjuvant radiotherapy. No recurrence or metastasis was detected in any of the patients during follow-up.
In the treatment of solitary fibrous tumors localized in extremity, marginal resection together with radiotherapy may be an alternative treatment method for patients in low risk group according to risk stratification model, for whom wide resection is not possible. Wide resection is recommended in moderate and high risk groups to decrease local recurrence and metastasis risks.
本研究旨在评估诊断为肢体孤立性纤维瘤患者的临床特征及治疗结果。
回顾性评估2005年1月至2016年12月期间诊断为肢体孤立性纤维瘤的7例患者(3例男性,4例女性;平均年龄49.7±20.7岁;范围22至79岁)的临床发现、治疗方法、临床结局及治疗失败情况。
最常见的部位是大腿(42.8%,n = 3)。平均肿瘤大小为10.8±2.4 cm(范围8 - 15 cm)。所有患者均因无痛性肿块就诊,且均为原发性肿瘤。诊断时所有患者均为局限性疾病。术后平均随访时间为44.4个月(范围13 - 121个月)。低风险组的2例患者行边缘性切除,而中高风险组的其他患者行广泛性切除。行边缘性切除的患者接受了辅助放疗。随访期间未发现任何患者复发或转移。
在肢体孤立性纤维瘤的治疗中,根据风险分层模型,对于无法进行广泛性切除的低风险组患者,边缘性切除联合放疗可能是一种替代治疗方法。对于中高风险组,建议行广泛性切除以降低局部复发和转移风险。